GENERIC DRUG USER FEE AMENDMENTS

USFDA issues warning letter to Sharon Bio-medicine

The US regulator has issued a warning letter to Sharon Bio-medicine for failing to pay generic drug user fee by its owner for three years starting 2013, saying its Dehradun-based facility would be barred from shipping products to the US if the dues are not cleared.